Model Portfolios | Institutional | News | Contact

CHIH

MSCI China Health Care ETF

Overview Prices & Performance Holdings & Characteristics Research Documents

Reasons to Consider CHIH

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Key Information As of 03/23/23

Inception Date	12/07/18
Total Expense Ratio	0.65%
Net Assets	$9.77 million
NAV	$16.29
Fact Sheet

ETF Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

ETF Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Trading Details As of 03/23/23

Ticker	CHIH
Bloomberg Index Ticker	NU722071
CUSIP	37954Y541
ISIN	US37954Y5419
Primary Exchange	NYSE Arca
Shares Outstanding	600,002
Number of Holdings	81
30-Day Median Bid-Ask Spread	1.34%

Distributions As of 03/23/23

30-Day SEC Yield	0.37%
Distribution Frequency	Semi-Annually

ETF Prices As of 03/23/23

NAV	$16.29	Daily Change	-$0.02	-0.12%
Market Price	$16.12	Daily Change	-$0.07	-0.43%

As of recent (12/31/22) As of recent (12/31/22)	Fund NAV	Market Price	Index
1 Year	-22.67%	-23.41%	-22.12%
3 Years	-1.61%	-1.99%	-0.91%
Since Inception	3.03%	2.74%	3.78%
1 Year	-10.75%	-11.37%	-10.11%
3 Years	-3.65%	-3.87%	-2.96%
Since Inception	2.79%	2.66%	3.54%
Year-to-Date	-22.67%	-23.41%	-22.12%
1 Month	4.39%	1.62%	4.43%
3 Months	25.30%	24.81%	25.66%
Since Inception	12.90%	11.61%	16.29%
Year-to-Date	-0.48%	0.12%	-0.37%
1 Month	-8.67%	-9.46%	-8.61%
3 Months	3.89%	1.75%	4.04%
Since Inception	12.36%	11.75%	15.86%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
8.56	6160 HK	BEIGENE LTD	BGDY260	16.98	49,239	836,154.08
8.39	2269 HK	WUXI BIOLOGICS CAYMAN INC	BL6B9P1	6.46	126,880	819,498.32
6.91	1093 HK	CSPC PHARMACEUTI	6191997	0.99	684,808	675,237.77
4.89	1177 HK	SINO BIOPHARMACEUTICAL	B00XSF9	0.56	848,300	477,659.78
4.44	1801 HK	INNOVENT BIOLOGICS INC	BGR6KX5	4.97	87,400	434,233.16
3.34	1099 HK	SINOPHARM GROUP CO-H	B3ZVDV0	2.89	112,900	326,487.64
3.28	1066 HK	SHANDONG WEIG-H	6742340	1.55	207,300	320,601.04
3.11	2359 HK	WUXI APPTEC CO LTD-H	BGHH0L6	10.45	29,056	303,526.50
2.82	300760 C2	SHENZHEN MINDR-A	BHQK864	45.75	6,017	275,293.87
2.49	1548 HK	GENSCRIPT BIOTECH CORP	BD9Q2J2	2.45	99,471	243,301.43
2.35	ZLAB	ZAI LAB LTD-ADR	BD9GVY0	31.46	7,306	229,846.76
2.20	6078 HK	HYGEIA HEALTHCAR	BMX09H0	7.50	28,600	214,599.28
2.15	600276 C1	JIANGSU HENGRU-A	BP3R369	6.26	33,572	210,149.74
1.95	867 HK	CHINA MEDICAL SY	B6WY993	1.58	119,900	190,014.40
1.93	3692 HK	HANSOH PHARMACEU	BJYKB72	1.79	105,300	188,339.94
1.83	LEGN	LEGEND BIOTECH CORP-ADR	BMX9K07	43.82	4,080	178,785.60
1.80	300015 C2	AIER EYE HSPTL-A	BD5CLQ4	4.50	39,048	175,859.64
1.64	603259 C1	WUXI APPTEC CO LTD-A	BHWLWV4	11.78	13,624	160,450.47
1.55	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	2.61	58,100	151,361.84
1.54	9926 HK	AKESO INC - B	BLFJ7Y1	5.37	28,000	150,349.69
1.47	2607 HK	SHANGHAI PHARM-H	B4Q4CJ6	1.92	74,700	143,315.29
1.45	600436 C1	ZHANGZHOU PIEN-A	BP3R7Z6	41.56	3,406	141,553.37
1.43	570 HK	TRAD CHI MED	6971779	0.54	260,600	139,434.63
1.39	1530 HK	3SBIO INC	BY9D3L9	1.00	136,700	136,182.78
1.37	2196 HK	FOSUN PHARMA-H	B8XBQ96	2.82	47,300	133,469.43
1.24	3320 HK	CHINA RESOURCES	BYNGG26	0.89	136,500	121,028.83
1.15	3347 HK	HANGZHOU TIGER-H	BMZC7F8	10.48	10,720	112,393.59
1.13	300122 C2	CHONGQING ZHIF-A	BD5CJY8	12.67	8,733	110,625.39
0.94	3759 HK	PHARMARON BEIJ-H	BK72QD3	5.24	17,575	92,020.40
0.91	000538 C2	YUNNAN BAIYAO-A	BD5CP95	7.89	11,314	89,228.67
0.89	300896 C2	IMEIK TECHNOLO-A	BNR4MY3	75.51	1,156	87,286.98
0.76	000963 C2	HUADONG MEDICINE CO LTD-A	BD5CM94	6.37	11,611	73,975.59
0.66	600196 C1	SHANGHAI FOSUN-A	BP3R3M5	4.71	13,574	63,960.58
0.60	600085 C1	BEIJING TONGRENTANG CO-A	BP3R5C9	7.44	7,900	58,803.96
0.60	603392 C1	BEIJING WANTAI-A	BMXTWX4	17.68	3,290	58,158.33
0.58	600332 C1	GUANGZHOU BAIY-A	BP3R4Q6	4.65	12,159	56,508.27
0.58	000661 C2	CHANGCHUN HIGH-A	BD5CDB3	24.59	2,290	56,313.98
0.54	002294 C2	SHENZHEN SALUBRIS PHARM-A	BD5CM05	5.19	10,200	52,910.45
0.53	300142 C2	WALVAX BIOTECHNOLOGY CO-A	BD5CG36	5.37	9,700	52,095.53
0.52	002001 C2	ZHEJIANG NHU CO LTD-A	BD5CH66	2.61	19,568	51,010.89
0.52	601607 C1	SHANG PHARM -A	BP3R4Z5	3.02	16,700	50,369.61
0.51	300347 C2	HANGZHOU TIGER-A	BD5CCK5	15.59	3,216	50,146.13
0.51	002422 C2	SICHUAN KELUN-A	BD5CL08	3.97	12,500	49,657.82
0.49	300759 C2	PHARMARON BEIJ-A	BK4XYC4	8.56	5,600	47,910.92
0.47	002603 C2	SHIJIAZHUANG Y-A	BD5CHJ9	4.20	11,027	46,329.69
0.47	000999 C2	CHINA RESOURCE-A	BD5CL42	7.88	5,800	45,725.10
0.47	000423 C2	DONG-E-E-JIAOCO LTD-A	BD5CM61	6.71	6,800	45,598.35
0.46	600998 C1	JOINTOWN PHARMACEUTICAL-A	BP3R541	2.18	20,770	45,247.23
0.43	300832 C2	SHENZHEN NEW-A	BMXTX20	8.34	5,000	41,692.03
0.42	002821 C2	ASYMCHEM LABOR-A	BD6V5C4	20.29	2,038	41,357.05
0.42	600079 C1	HUMANWELL HEAL-A	BP3R712	3.81	10,700	40,733.35
0.41	002044 C2	MEINIAN ONEHEA-A	BD73L10	0.98	41,020	40,017.16
0.41	002252 C2	SHANGHAI RAAS -A	BD5CPJ5	0.92	43,400	39,855.94
0.41	300003 C2	LEPU MEDICAL TECHNOLOGY-A	BD5CM16	3.45	11,501	39,649.02
0.40	603882 C1	GUANGZHOU KING-A	BFYX689	12.60	3,100	39,069.19
0.39	002007 C2	HUALAN BIOLOGI-A	BD5CL19	3.29	11,670	38,382.70
0.39	600763 C1	TOPCHOICE MEDI-A	BYYFJH8	19.36	1,980	38,341.41
0.37	603858 C1	SHANDONG BUCHA-A	BYW5NC3	2.90	12,587	36,468.54
0.35	688363 C1	BLOOMAGE BIOTE-A	BP91NT8	16.16	2,097	33,888.42
0.34	688180 C1	SHANGHAI JUNSH-A	BLCD7F7	7.21	4,642	33,490.58
0.34	300601 C2	SHENZHEN KANGT-A	BFY8HT2	4.75	7,048	33,458.26
0.32	603456 C1	ZHEJIANG JIUZH-A	BMQBVL8	5.47	5,700	31,173.08
0.31	300595 C2	OVCTEK CHINA INC-A	BHQPSJ2	4.82	6,224	29,984.84
0.30	600521 C1	ZHEJIANG HUAHA-A	BP3RBR6	2.91	10,010	29,134.31
0.30	002223 C2	JIANGSU YUYUE-A	BD5CJM6	4.46	6,500	28,997.38
0.29	000739 C2	APELOA PHARMA-A	BD5LY17	3.28	8,500	27,894.20
0.28	300357 C2	ZHEJIANG WOLWO-A	BFY8GY0	7.32	3,723	27,242.60
0.27	300676 C2	BGI GENOMICS CO LTD-A	BFY8H58	8.72	3,033	26,460.58
0.27	603707 C1	NANJING KING-F-A	BF2DZL7	2.33	11,236	26,224.72
0.27	300529 C2	JAFRON BIOMEDI-A	BFY8H03	4.48	5,800	25,993.71
0.27	600380 C1	JOINCARE PHARM-A	BP3RBV0	1.88	13,800	25,913.02
0.26	600566 C1	HUBEI JUMPCAN -A	BS7K3N2	4.17	6,200	25,830.87
0.26	300558 C2	BETTA PHARMACE-A	BD6QWL7	8.19	3,120	25,548.97
0.26	688301 C1	IRAY TECHNOLOGY CO LTD-A	BQ3RXC2	52.83	482	25,463.80
0.25	300363 C2	PORTON PHARMA -A	BD5LZ92	6.16	4,000	24,639.67
0.25	603127 C1	JOINN LABORATO-A	BK94819	7.97	3,040	24,229.38
0.25	000513 C2	LIVZON PHARM-A	BD5CQ25	5.11	4,700	24,001.09
0.24	002030 C2	DAAN GENE CO LTD-A	BD5CKW3	2.31	10,160	23,445.06
0.23	600056 C1	CHINA MEHECO CO LTD -A	BP3R8X1	2.07	11,000	22,817.66
0.13	688202 C1	SHANGHAI MEDICILON INC-A	BNR4NV7	24.00	547	13,125.62
0.10	603658 C1	AUTOBIO DIAGNO-A	BYW5N89	8.68	1,100	9,553.08
0.04		CASH		1.00	4,127	4,127.41
0.00		HONG KONG DOLLAR		0.00	0	0.00
0.00		CHINESE YUAN RENMINBI		0.15	-1	-0.09

Holdings are subject to change. "Cash" denotes U.S. dollars.

ETF Characteristics As of 03/23/23

Return on Equity	9.70%
Weighted Avg. Market Cap	14,032 M
	2022	2023
Price-to-earnings	42.58	28.60
Price-to-book value	2.87	2.68

Source: AltaVista Research, LLC

ETF Risk Stats As of 02/28/23

Versus	Beta
S&P 500	0.52
MSCI EAFE	0.69
MSCI Emg. Mkts	0.98
Standard Deviation	32.00%

Source: AltaVista Research, LLC

ETF Research

J.P. Morgan Healthcare Conference: New Catalysts Set to Transform Patient Care

View More Related Research

ETF Documents

Latest Premium / Discount As of 03/23/23

NAV	$16.29
Market Price	$16.12
Premium / (Discount)	($0.17)

Current View 2023 Q1 As of 03/23/23

Days at Premium	23
Days at NAV	0
Days at Discount	33
Greatest Premium	1.54%
Greatest Discount	-2.12%

Daily Premium / Discount History As of 03/23/23

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.